

Prestige Consumer Healthcare acquires Breathe Right brand for $1.045 billion. Deal expands OTC portfolio into sleep & breathing categories.
You can purchase shares of Prestige Consumer (NYSE:PBH) through any online brokerage.
Other companies in Prestige Consumer’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Prestige Consumer has a consensus price target of $83.00.
The stock price for Prestige Consumer (NYSE: PBH) is $53.28 last updated November 4, 2026 at 4:00 PM EST.
There are no upcoming dividends for Prestige Consumer.
Prestige Consumer does not have any upcoming earnings scheduled.
There is no upcoming split for Prestige Consumer.
Prestige Consumer is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief),...